YIMLAMAI LAB
  • Home
  • Principal Investigator
  • Our Research
  • Team
  • Lab News
  • Publications
  • Available Positions
  • Contact
  • Home
  • Principal Investigator
  • Our Research
  • Team
  • Lab News
  • Publications
  • Available Positions
  • Contact
Search

Our Mission:

Improving the Care of Children and Adults with Chronic Liver Disease

Our paper on Cyr61 in NASH Fibrosis is out and on the cover of Science Translational Medicine.

Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis.
Mooring et al. 
Sci Transl Med. 2023 Sep 27;15(715):eade3157.


Picture

Picture
(© stock.adobe.com)
 Protein that drives liver damage could be a new target for treatment (Yale News)
​
Yale researchers have identified a protein that drives symptoms of severe liver disease and may be a target for treatment in the future.

Picture
medicine.yale.edu/news-article/researchers-at-yale-demonstrate-new-protective-process-against-liver-fibrosis-in-nash/Researchers Demonstrate New Protective Process Against Liver Fibrosis in NASH
Picture
Proudly powered by Weebly
  • Home
  • Principal Investigator
  • Our Research
  • Team
  • Lab News
  • Publications
  • Available Positions
  • Contact